|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Net Income/(Loss) | |||||
| Adjustments to Reconcile Net Income/(Loss) to Net Cash Provided by/(Used in) Operating Activities | |||||
| Lifted Made's Portion of SmplyLifted's Net Loss | |||||
| Impairment of Investment in SmplyLifted | |||||
| Deferred Contingent Stock Compensation Expense | |||||
| Impairment of Investment in Ablis | |||||
| Impairment of Investment in Bendistillery | |||||
| Impairment of Goodwill | |||||
| Provision for Credit Losses - Extrax NM Loans | |||||
| Sales Allowance | |||||
| Spoiled and Written Off Inventory | |||||
| Bad Debt Expense | |||||
| Depreciation and Amortization | |||||
| Loss/(Gain) on Lease Modification | |||||
| Loss From Inventory Theft | |||||
| Settlement Income | |||||
| Debt Financing Expenses | |||||
| Loss on Disposal of Fixed Assets | |||||
| Loss on Jeeter Collab | |||||
| Loss on Deposits | |||||
| Gain on Forgiveness of Debt | |||||
| Deferred Income Taxes | |||||
| Effect on Cash of Changes in Operating Assets and Liabilities | |||||
| Prepaid Expenses | |||||
| Dividend Receivable from Bendistillery, Inc. | |||||
| Accounts Receivable | |||||
| Inventory | |||||
| Other Current Assets | |||||
| Change in Right Of Use Asset | |||||
| Change in Receivable Loans from Extrax NM | |||||
| Other Assets | |||||
| Income Tax Receivable and Payable, net | |||||
| Management Bonuses Payable | |||||
| Company-wide Management Bonus Pool | |||||
| Interest Receivable | |||||
| Collab Commissions and Royalties Payable | |||||
| Deferred Revenue | |||||
| Accounts Payable and Accrued Expenses | |||||
| Accounts Payable and Interest Payable to Related Parties | |||||
| Change in Settlement Asset and Receivables | |||||
| Change in Finance and Operating Lease Liabilities | |||||
| Net Cash Provided By/(Used In) Operating Activities | |||||
| Cash Flows From Investing Activities | |||||
| Net Cash Paid as Part of the Oculus Transaction | |||||
| Reduction of CBD Lion Note Receivable | |||||
| Purchase of Headquarters Building | |||||
| Purchases of Fixed Assets | |||||
| Loans to SmplyLifted LLC | |||||
| Proceeds from Disposal of Fixed Assets | |||||
| Net Cash Used in Investing Activities | |||||
| Cash Flows From Financing Activities | |||||
| Proceeds from Exercise of Warrants and Options | |||||
| Issuance of Common Stock | |||||
| Proceeds from Related Party Note | |||||
| Repayment of Interest Payable to Related Parties | |||||
| Payments on Related Party Note | |||||
| Proceeds from Surety Bank Loans | |||||
| Payments on Surety Bank Loans | |||||
| Payments of Dividends to Preferred Stockholders | |||||
| Payments of Dividends to Series B Convertible Preferred Stockholders | |||||
| Payment of Debt Financing Costs | |||||
| Purchase of Shares of Common Stock | |||||
| Payments on Finance Lease Liability | |||||
| Net Cash Provided by/(Used In) Financing Activities | |||||
| Cash and Cash Equivalents at Beginning of Period | |||||
| Cash and Cash Equivalents at End of Period | |||||
| Net Increase/(Decrease) in Cash | |||||
| Cash, Cash Equivalents and Restricted Cash at Beginning of Period | |||||
| Cash, Cash Equivalents and Restricted Cash at End of Period | |||||
| Supplemental Cash Flow Information | |||||
| Cash Paid For Interest | |||||
| Right-of-Use assets acquired from inception of Finance Leases | |||||
| Cash Paid For Interest - Related Party | |||||
| Cash Paid/(Received) For Income Taxes | |||||
| Right-of-Use assets acquired from inception of Finance Leases | |||||
| Right-of-Use assets acquired from inception of Operating Leases | |||||
| Conversion of Series A and Series B Preferred Stock to Common Stock | |||||
| Cashless exercise of Warrants | |||||
| Cancellation of Common Stock held in Treasury | |||||
| Reduction in bonus payable to Gerard M. Jacobs by the cost of exercising warrants | |||||
| Non-Cash Activities | |||||
| Right-of-Use assets acquired from inception of Operating Leases | |||||
| Issuance of stock component of the second installment of Merger Consideration (the issuance of 160,000 shares of common stock) pursuant to the Oculus Merger Agreement, on May 13, 2024 | |||||
| Conversion of Series A and Series B Preferred Stock to Common Stock | |||||
| Cash and Cash Equivalents | |||||
| Restricted Cash | |||||
| Cash and Cash Equivalents | |||||
| Restricted Cash | |||||
| Total Cash, Cash Equivalents and Restricted Cash at End of Period | |||||
Loading...